Intracranial hemorrhage

There are 118 papers on intracranial hemorrhage in aging research: 6 trials and 86 observational studies in people, 2 in animals, 21 reviews. The newest story, Nov 7, 2026: “Diabetes drugs linked to lower dementia risk after minor stroke”.

Disease

118 papers study it42 more mention it35 findings

MeSH

11 new papers in 30 daysSee all 160 papers on intracranial hemorrhage

At a glance

Intracranial hemorrhage is linked with mortality in nonagenarians after ground-level falls and in geriatric patients undergoing craniotomy for traumatic brain injury. Human cohorts link higher blood pressure with greater hemorrhage risk in atrial fibrillation; antithrombotic associations vary across trauma populations. A human trial reports fewer hemorrhages with edoxaban than warfarin in atrial fibrillation.

35 findings in 33 papers from 2005 to 2026, 8 of them since May 2026

“and nonsignificantly increased the risk of intracranial hemorrhage”
Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention ProjectStroke2016doi:10.1161/strokeaha.115.012461
  • Human trial6
  • Humans86
  • Animals2
  • In silico3

Interventions

5

GLP-1 receptor agonists

no changein humans1

1 study
  1. GLP-1 receptor agonists were not clearly linked with intracranial hemorrhage in humans (Minor ischemic stroke; diabetes present in 92.7%).

    HumansMinor ischemic stroke; diabetes present in 92.7%5 years

    Diabetes drugs linked to lower dementia risk after minor stroke

    Journal of neurology

More on GLP-1 receptor agonists

Anticoagulation

no changein humans1

1 study
  1. Anticoagulation was not clearly linked with intracranial hemorrhage in humans (Atrial fibrillation) (Rates 1.3-1.6% across groups).

    HumansAtrial fibrillation

    Blood thinners tied to survival at 80 and up with atrial fibrillation

    Journal of general internal medicine

More on Anticoagulation

Antithrombotic agents

no changein humans1

1 study
  1. Antithrombotic agents were not clearly linked with intracranial hemorrhage in humans (older trauma patients) (74% vs. 71%, p = 0.85).

    Humansolder trauma patientsn = 1,112

More on Antithrombotic agents

Lipophilic statins

no changein humans1OR 1.07

1 study
  1. Lipophilic statins were not clearly linked with intracranial hemorrhage in humans after ischemic stroke; hydrophilic statins as reference group (adjusted OR 1.07 (95% CI 0.97-1.19)).

    Humansafter ischemic stroke; hydrophilic statins as reference groupn = 11,060

More on Lipophilic statins

Edoxaban

downin humans1

1 study
  1. Edoxaban decreases intracranial hemorrhage in humans (patients with atrial fibrillation, compared with warfarin) (-73 events/10 000 pt-yrs).

    Human trialpatients with atrial fibrillation, compared with warfarinn = 8,474

More on Edoxaban

Upstream

3

Older-adults

no changein humans1

1 study
  1. older-adults were not clearly linked with intracranial hemorrhage in humans (acute ischemic stroke treated with intravenous alteplase).

    Humansacute ischemic stroke treated with intravenous alteplasen = 52

RpS20

downin zebrafish1

1 study
  1. RpS20 prevents intracranial hemorrhage in zebrafish (shown by CRISPR/Cas9 knockout) (marked increase in incidence (no number given)).

    Animalsshown by CRISPR/Cas9 knockout

More on RpS20

Growth hormone deficiency

upin rodent1

1 study
  1. Growth hormone deficiency increases intracranial hemorrhage in rodent (compared with heterozygous animals) (+154% (GHD) and +198% (AO-GHD)).

    Animalscompared with heterozygous animals

More on Growth hormone deficiency

Associations

19

Direct oral anticoagulants

downin humans4HR 0.23

4 studies
  1. Direct oral anticoagulants are linked with a lower risk of intracranial hemorrhage in humans (CrCl ≥ 45 ml/min/1.73 m2) (0.2% vs 2.8%, p = 0.01).

    HumansCrCl ≥ 45 ml/min/1.73 m2n = 598

  2. Direct oral anticoagulants are linked with a lower risk of intracranial hemorrhage in elderly non-valvular atrial fibrillation patients.

    Humansin elderly non-valvular atrial fibrillation patients

  3. Direct oral anticoagulants are linked with a lower risk of intracranial hemorrhage in humans (non-valvular atrial fibrillation) (HR 0.23 [95% CI 0.10-0.56]).

    Humansnon-valvular atrial fibrillation5-year

  4. Direct oral anticoagulants lower the risk of intracranial hemorrhage in humans (atrial fibrillation).

    Reviewatrial fibrillation

More on Direct oral anticoagulants

Aspirin

upin humans3HR 1.463

3 studies
  1. Aspirin raises the risk of intracranial hemorrhage in humans (HR 1.463, 95% CI 0.956–2.237; P=0.078; nonsignificant).

    Human trialJapanese patients with hypertension, dyslipidemia, and diabetes mellitus; compared with no aspirin100 mgMedian follow-up of 5.02 yearsn = 14,464

  2. Aspirin is associated with intracranial hemorrhage in humans (admitted after ground level falls).

    Humansadmitted after ground level falls

  3. Aspirin raises the risk of intracranial hemorrhage in humans.

    Review

More on Aspirin

Systolic blood pressure

upin humans2RR 1.27–1.51

2 studies
  1. Systolic blood pressure is linked with a higher risk of intracranial hemorrhage in individuals with atrial fibrillation (RR 1.51 at 140 vs 120 mmHg; 1.99 at 150 mmHg).

    Humansin individuals with atrial fibrillation

  2. Systolic blood pressure is associated with intracranial hemorrhage in humans (patients with atrial fibrillation) (27% higher risk per 10 mmHg; RR 1.27 (95% CI 1.12–1.44)).

    Reviewpatients with atrial fibrillationeach 10 mmHg increase

More on Systolic blood pressure

Statins

downin humans2HR 0.59–0.725

2 studies
  1. Statins are linked with a lower risk of intracranial hemorrhage in humans (HR 0.725 [0.660–0.796]).

    Humans1 year

  2. Statins are linked with a lower risk of intracranial hemorrhage in humans (atrial fibrillation and recent ischaemic stroke) (HR: 0.59, 95%CI: 0.47-0.72, p<0.001).

    Humansatrial fibrillation and recent ischaemic stroke2 yearsn = 11,182

More on Statins

Mortality

upin humans2OR 2.251–5.9

2 studies
  1. Intracranial hemorrhage is linked with a higher risk of mortality in humans (geriatric traumatic brain injury who underwent craniotomy) (OR = 2.251, p < 0.001).

    Humansgeriatric traumatic brain injury who underwent craniotomyn = 20,303

  2. Intracranial hemorrhage predicts mortality in humans (1-month mortality in nonagenarians admitted for ground-level falls) (OR = 5.9, 95% CI 2.5-14).

    Humans1-month mortality in nonagenarians admitted for ground-level falls1 monthn = 1,014

Alcohol-prominent multi-trajectory pattern

upin humans1OR 1.19

1 study
  1. Alcohol-prominent multi-trajectory pattern is associated with intracranial hemorrhage in humans (Alcohol-prominent group compared with Low-smoking inactive group) (OR 1.19, 95% CI 1.12–1.27).

    HumansAlcohol-prominent group compared with Low-smoking inactive groupSix-year preindex trajectories

Serum magnesium

upin humans1HR 1.74

1 study
  1. Serum magnesium predicts intracranial hemorrhage in humans (serum magnesium <1.7 mg/dL) (HR, 1.74; 95% CI, 1.59-1.89).

    Humansserum magnesium <1.7 mg/dL5 yearsn = 266,133

More on Serum magnesium

Leukoencephalopathy

upin humans1

1 study
  1. Leukoencephalopathy is linked with a higher risk of intracranial hemorrhage in humans (unruptured intracranial aneurysm surgery) (p = 0.0017).

    Humansunruptured intracranial aneurysm surgeryn = 397

More on Leukoencephalopathy

Frailty

upin humans1

1 study
  1. Frailty is associated with intracranial hemorrhage in humans (acute pulmonary embolism) (aOR: 3.9, 95 % CI: 3.3-4.7, p < 0.001).

    Humansacute pulmonary embolism

Severe frailty

no changein humans1OR 2.34

1 study
  1. Severe frailty is associated with intracranial hemorrhage in humans (ground-level fall-related, mild TBI) (OR 2.34 (95% CI 0.41-13.6), p = 0.34).

    Humansground-level fall-related, mild TBIn = 335

All 19

Trial sponsors

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 1Jan 2026: 5Feb 2026: 9Mar 2026: 3Apr 2026: 0May 2026: 4Jun 2026: 1Jul 2026: 2Aug 2026: 6Sep 2026: 1Oct 2026: 6Nov 2026: 846 papers in 12 months
Journal of Neurology

Diabetes drugs linked to lower dementia risk after minor stroke

Over five years, dementia occurred in 3.4% of drug users versus 7.0% of nonusers in a matched comparison of people with minor strokes.Over five years, dementia occurred in 3.4% of drug users versus 7.0% of nonusers in a matched comparison of people with minor strokes.

Cohort studyPopulations
AHA Scientific Sessions 2026 Abstract

Add-ons linked to fewer strokes in treated hypertension with obesity

Stroke rates were 3.4% with one add-on drug class versus 4.0% with blood-pressure drugs alone; mean follow-up across comparisons ranged from 3.6–4.2 years.Stroke rates were 3.4% with one add-on drug class versus 4.0% with blood-pressure drugs alone; mean follow-up across comparisons ranged from 3.6–4.2 years.

Cohort studyObesity
The Journal of Nutrition

One omega-3 in body fat linked to lower bleeding stroke risk

A relative risk measure was 0.64 for the highest versus lowest fifth of eicosapentaenoic acid in body fat over a median 21 years.A relative risk measure was 0.64 for the highest versus lowest fifth of eicosapentaenoic acid in body fat over a median 21 years.

Cohort · 54,546 peoplePopulations
Journal of General Internal Medicine

Blood thinners tied to survival at 80 and up with atrial fibrillation

One-year mortality was 8.7% among people who continued blood thinners, versus 17.7% among those who never took them, in a retrospective cohort study.One-year mortality was 8.7% among people who continued blood thinners, versus 17.7% among those who never took them, in a retrospective cohort study.

Cohort · 45,305 peopleAtrial fibrillation

See all 160 papers on intracranial hemorrhage